Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Leptospermum scoparium (Manuka) and Staphylococcus Infections: Evidence Overview

Leptospermum scoparium, commonly known as manuka, is widely recognized for its antimicrobial properties, particularly in the form of manuka honey. The use of manuka honey for treating skin infections, including those caused by Staphylococcus aureus (including MRSA), is supported by a growing body of scientific literature.

In vitro studies have consistently demonstrated that manuka honey possesses significant bactericidal activity against Staphylococcus species. This is primarily attributed to its high methylglyoxal (MGO) content, which is unique among honeys. Several clinical studies and case reports have documented the successful use of manuka honey in wound care, showing reduced bacterial load and promotion of wound healing, even in chronic, non-healing wounds infected with resistant strains of Staphylococcus. The mechanisms of action include osmotic effects, low pH, and the presence of bioactive compounds like MGO and hydrogen peroxide.

While the bulk of high-quality evidence is limited to topical applications (such as dressings for wounds and ulcers), and not oral or systemic treatment, the scientific literature does support the use of manuka honey as an adjunctive therapy in managing superficial Staph infections. Major clinical guidelines have yet to universally endorse its use due to a lack of large-scale randomized controlled trials, but the existing data justify a moderate evidence rating.

In summary, Leptospermum scoparium (as manuka honey) is scientifically validated for topical support in Staph infection management, though more robust clinical trials are warranted to fully define its role.

More about Leptospermum scoparium
More about Staph Infections

Other ingredients used for Staph Infections

Other health conditions supported by Leptospermum scoparium

Products containing Leptospermum scoparium